Hypo-sensitization Market

Hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
Hypo-sensitization Market contains market size and forecasts of Hypo-sensitization in Global, including the following market information:
Global Hypo-sensitization Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hypo-sensitization market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Subcutaneous Immunotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hypo-sensitization include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, WOLW Pharma, HAL, Holister Stier and Leti, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hypo-sensitization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypo-sensitization Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hypo-sensitization Market Segment Percentages, by Type, 2021 (%)
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Global Hypo-sensitization Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hypo-sensitization Market Segment Percentages, by Application, 2021 (%)
Allergic Rhinitis
Allergic Asthma
Other
Global Hypo-sensitization Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hypo-sensitization Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypo-sensitization revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hypo-sensitization revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
WOLW Pharma
HAL
Holister Stier
Leti